Phreesia, Inc. - PHR STOCK NEWS

Phreesia has achieved Oracle Validated Integration with Oracle Health Electronic Health Record (EHR) Expertise for its patient intake platform integration. The validation confirms the integration's functionality and performance, enabling healthcare organizations to enhance patient experience and operational efficiency. Phreesia's research shows that Oracle customers using their platform have experienced significant improvements, including a 25% increase in payment collections, 77% copay collection at time of service, and staff saving over five minutes per visit with 87% of patients using self-check-in.

Phreesia, a leader in patient activation, has joined the Network Advertising Initiative (NAI), a non-profit organization dedicated to responsible data collection and use in digital advertising. This move demonstrates Phreesia's commitment to consumer data privacy and industry-leading privacy practices.

As an NAI member, Phreesia will:

• Promote consumer-centric privacy practices in healthcare
• Take a leadership role in shaping the national conversation around data privacy
• Advocate for national policies that allow beneficial use of healthcare data while preserving consumer privacy

Phreesia's platform focuses on personalized health content built on principles of privacy and consent. The company's research shows that consumers value receiving relevant health information, with over 80% of surveyed individuals appreciating personalized content about medications or therapies related to their health conditions.

Phreesia, a leader in patient intake, has partnered with the Ad Council to deliver three mental health awareness campaigns to patients and caregivers. The campaigns have reached over 430,000 individuals, focusing on youth, adult, and adolescent mental health. Key findings show that most viewers plan to discuss mental health with doctors, family, or friends, and over half are likely to seek additional information.

The campaigns include:

• 'Seize the Awkward': Targeting young adults 18-24, delivering 255,000 messages
• 'Sound It Out': Aimed at parents of middle schoolers and teens, with 60,000 messages
• 'Love, Your Mind': Focused on Black and Hispanic men, delivering 117,000 messages

Results indicate high engagement, with many recipients requesting resources and expressing intentions to discuss mental health with healthcare providers or loved ones. The partnership aims to normalize mental health discussions and provide tools for important conversations.

Phreesia, a leader in patient intake and activation, has renewed its contract with the CMS Innovation Center (CMMI) for the use of the Patient Activation Measure® (PAM) through 2029. The PAM assesses patients' knowledge, skills, and confidence in managing their healthcare. This renewal follows the success of the Kidney Care Choices (KCC) Model, which aims to improve care for Medicare beneficiaries with chronic kidney disease.

The first annual evaluation of the KCC model revealed significant improvements, including:

• An average 8.8-point increase in PAM scores
• A 20% increase in home dialysis
• A 16% increase in optimal ESRD starts
• A 15% increase in patients on the transplant waitlist

These results demonstrate the effectiveness of patient activation in improving healthcare outcomes and reducing costs. Phreesia's continued partnership with CMMI may lead to expanded use of PAM in additional healthcare models and settings.

New research by Phreesia reveals that delivering digital vaccine-related messages to patients before medical appointments significantly increases vaccine uptake. The study, analyzing over 20.2 million digital vaccine messages across all 50 states between March 2020 and May 2024, found that patients exposed to point-of-care messages received vaccinations at a rate more than twice as high as control groups. Key findings include:

- 49% of patients said the information was new to them
- 65% were likely to discuss vaccines with their doctor
- In some cases, messaging drove vaccine administration rates more than 10X higher than the control group

The research demonstrates the effectiveness of providing timely, credible vaccine information in supporting vaccine confidence and adoption, even among historically marginalized populations and during periods of increased vaccine hesitancy.

The CDC has awarded a research grant to a joint project involving Phreesia, the National Association For Continence (NAFC), Health.Equity.Outcomes., and Dr. Christina Escobar to address the public health challenge of urinary incontinence (UI) in women. The project aims to raise awareness and empower women to seek treatment for UI, which affects nearly 100 million women in the U.S. but remains underdiagnosed and undertreated.

The initiative will leverage Phreesia's digital patient engagement platform to deploy a campaign encouraging women to discuss UI with their healthcare providers. The project will also focus on creating an indicator report on UI prevalence, developing survey questions, and publishing educational content on screening, prevention, and treatment options.

Phreesia (NYSE: PHR) reported strong financial results for Q2 fiscal 2025, ending July 31, 2024. Highlights include:

- Total revenue of $102.1 million, up 19% year-over-year
- Average healthcare services clients (AHSCs) of 4,169, up 21% year-over-year
- Net loss of $18.0 million, improved from $36.8 million loss in prior year
- Adjusted EBITDA of $6.5 million, up from negative $11.5 million
- Positive free cash flow of $3.7 million

The company maintained its fiscal 2025 revenue outlook of $416-426 million and raised Adjusted EBITDA guidance to $26-31 million. Phreesia expects continued growth in AHSCs and revenue per AHSC through fiscal 2026.

Phreesia, a patient intake and activation leader, has partnered with the American Academy of Pediatrics (AAP) to boost measles, mumps, and rubella (MMR) vaccination rates among children. The campaign targets caregivers of children aged 9 months to 6 years who haven't completed the MMR series. It will run on Phreesia's digital intake platform, providing educational content about AAP recommendations for MMR immunization.

The collaboration aims to address the dip in immunization rates, with the national MMR vaccination rate for kindergartners at 93%, below the 95% threshold for community immunity. AAP recommends the first MMR vaccine between 12-15 months and a second dose at 4-6 years. The campaign leverages Phreesia's platform, which enabled about 150 million patient visits in 2023, to deliver important vaccination information at the point of care.

Phreesia, a leader in patient intake, outreach and activation, has named Bob Glazer as a Strategic Advisor. Glazer, with over 45 years of healthcare leadership experience, is currently the President of Glazer Business Advisors. He previously served as CEO of ENT and Allergy Associates (ENTA) for 27 years, growing it from 12 to 250 providers across 50+ locations. Phreesia COO Evan Roberts expressed excitement about Glazer's appointment, citing his understanding of medical practices' on-the-ground reality. Glazer aims to help the next generation of physicians and views his advisory role at Phreesia as a means to achieve this goal. Phreesia, founded in 2005, enabled approximately 150 million patient visits in 2023, representing more than 1 in 10 visits across the U.S.